Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
21,338 total articles
SpyGlass Pharma announced that the AMA CPT Editorial Panel has approved a new add-on Category III CPT code for their BIM-IOL System, a drug-eluting intraocular lens implant designed to treat glaucoma and cataracts in a single surgery. This reimbursement code supports utilization tracking and future coverage, helping pave the way for product commerc…
Enlivex Ltd. has dosed the first patient in the United States as part of its global Phase 2b clinical trial evaluating Allocetra for treating moderate-to-severe age-related primary knee osteoarthritis. Following FDA IND clearance and Danish regulatory approval, the trial will assess efficacy and safety across multiple countries, targeting an unmet …
Silicon Motion Technology Corporation, a leading supplier of NAND flash controllers worldwide, announced its participation in several prestigious investor conferences throughout May and June 2026, including J.P. Morgan, B. Riley Securities, Morgan Stanley Asia AI Summit, Evercore Global TMT Conference, Citi Taiwan Tech Conference, and Bank of Ameri…
LGI Homes, Inc. has opened Cypress Trails, a premier master-planned community in Hockley near Cypress, Texas. This development features over 500 homes with a range of layouts and price points starting from the mid-$200,000s, complemented by resort-style amenities such as parks, pickleball courts, and walking trails. Positioned strategically with ea…
Enhanced Group announced a strategic multi-million dollar partnership with Rezolve Ai to utilize AI-powered technologies for its Live Enhanced consumer platform and the inaugural Enhanced Games. The collaboration will start with a mobile-first AI-enabled web experience for event attendees, featuring ticketing, athlete information, and real-time eng…
Alaunos Therapeutics announced updated preclinical results for ALN1003, their oral metabolic therapeutic candidate, demonstrating positive effects on insulin-resistance-related biomarkers, adipose tissue endocrine markers, and liver histology in diet-induced obesity mouse models. These findings support continued preclinical development for metaboli…
BIO-key International, Inc., a provider of biometric identity and access management solutions, reported a 34% revenue increase in Q1 2026 to $2.15 million and a substantially improved net loss of $165,000 versus $737,000 in the prior year period. The company expects Q2 revenues to rise 65% with profitability anticipated in the first half of 2026, d…
Core AI Holdings, Inc. reported a 58.6% year-over-year revenue increase to $55.2 million for 2025, driven by strategic focus on AI infrastructure and divestment of legacy business units. Despite short-term losses from restructuring and discontinued operations, the company is positioned for long-term growth in AI and digital platforms.
Safe Harbor Financial, a NASDAQ-listed fintech company serving the cannabis and hemp financial services markets, reported Q1 2026 revenue of approximately $2 million, marking a 2.2% year-over-year increase. The company expanded its loan program income by 55.6% due to a restructured agreement and diversified its offerings into insurance and retireme…
CervoMed reported Q1 2026 financial results and significant clinical progress, including alignment with regulatory agencies on a Phase 3 trial design for neflamapimod in dementia with Lewy bodies (DLB). New MRI and biomarker data support neflamapimod's potential as a disease-modifying therapy. Ongoing studies in frontotemporal disorders and ALS als…
Anterix (NASDAQ: ATEX) and Lynk Global have received experimental license approval from the FCC to test the integration of Lynk's satellite direct-to-device network with Anterix's licensed 900 MHz private wireless broadband spectrum. This collaboration aims to develop private, secure, resilient communication solutions for critical infrastructure se…
Inspira Technologies secured a $580,000 purchase order from NYU Langone Hospital for its FDA-cleared ART100 extracorporeal blood circulation systems after a multi-patient clinical evaluation demonstrated the system's operational value. This commercial milestone supports ongoing strategic discussions and promotes Inspira's medical technology busines…
Duos Technologies reported a strategic $200 million partnership with Hydra Host to deploy cutting-edge GPU infrastructure, supporting the company's aim to exceed $50 million in revenue for 2026. Despite a Q1 revenue decline versus the prior year due to legacy business ramp-down, Duos strengthened its balance sheet through a $65 million capital rais…
FG Nexus Inc. announced the declaration of a quarterly cash dividend of $0.50 per share on its 8.00% Cumulative Preferred Stock, Series A, payable June 15, 2026. This marks the 33rd consecutive quarterly dividend payment, reflecting the company's ongoing commitment to returning capital to its preferred shareholders while advancing its digital asset…
Armlogi Holding Corp. announced new internal financial reporting and management infrastructure initiatives including standardized cash flow reporting, higher-frequency monitoring, integrated cross-functional forecasting, and workforce allocation analysis. These measures aim to enhance management visibility, budgeting discipline, and coordination ac…
BrainsWay Ltd. has announced a strategic minority-stake investment in Hopemark Health, a mental health clinic management services organization. The initial $1.5 million investment, with potential additional milestone-based funding, aims to enhance access to advanced interventional psychiatry treatments such as Deep Transcranial Magnetic Stimulation…
Streamex Corp. announced the distribution of its second monthly yield payment for GLDY, a gold-backed, yield-bearing tokenized security, reflecting successful deployment of gold reserves into an institutional gold leasing program yielding 3.5% annually. The company emphasizes continued scaling and secondary trading venue rollouts for GLDY.
NervGen Pharma Corp. reported Q1 2026 financial results highlighting completion of a successful FDA End-of-Phase 2 meeting aligning study parameters for RESTORE, a pivotal trial for NVG-291 in chronic tetraplegia. Site activations are underway, targeting study initiation in mid-2026. The company completed its Nasdaq uplisting, strengthened its lead…
An independent, NIMH-funded study of over 6,200 U.S. college students found that Amwell's SilverCloud digital behavioral health platform reduces the prevalence of mental disorders by up to 3.8% over two years. The proactive care model led to higher engagement rates than traditional behavioral health solutions and demonstrated potential economic sav…
urban-gro, Inc. (NASDAQ: UGRO), via its subsidiary Innovative Production Group (IPG), confirms full franchise lineup and new ownership groups for Lanka Premier League (LPL) Season 6 scheduled for July-August 2026. The firm gains exposure across the league's media, sponsorship, and activation economics. Newly named ownership includes U.S.-based inve…
Diana Shipping Inc., a leading dry bulk shipping company and largest shareholder of Genco Shipping & Trading Limited, cautions that Genco's current share price is artificially inflated due to Diana's $23.50 per share acquisition offer. Diana warns that without their offer, Genco's stock could fall to approximately $17.50 per share, reflecting a his…
IREN Limited, a NASDAQ-listed AI Cloud data center and GPU cluster provider, has acquired Awaken, a creative and media agency that has been its external marketing partner. Bringing Awaken's team in-house aims to strengthen IREN's brand awareness and marketing capabilities as it expands into new regions including North America, Europe, and APAC. Thi…
NRx Pharmaceuticals reported significant progress in Q1 2026 including anticipated FDA decision on preservative-free ketamine ANDA, initiation of commercial manufacturing at 1 million doses per month, FDA acceptance of NRX-101 IND for adjunct TMS therapy, expansion of interventional psychiatry clinics, and pending acquisition of assets targeting se…
Onfolio Holdings Inc., a Nasdaq-listed owner-operator of cash-generative online businesses, announced its Q1 2026 financial results. The company posted a decrease in revenue and gross profit compared to Q1 2025 but significantly improved operating margins through cost reductions and an AI-driven operating model. Onfolio secured a $100 million equit…
Can-Fite BioPharma and Vetbiolix published a peer-reviewed study demonstrating Piclidenoson significantly improves clinical signs of canine osteoarthritis with a favorable safety profile. This validates Piclidenoson’s potential as an oral disease-modifying therapy in a large veterinary market. The drug is under development by Vetbiolix through a li…
